The Vietnam Youth Symphony Orchestra (VYO) is taking shape with the support and strategic cooperation from the Vietnam National Symphony Orchestra (VNSO). This move aims to create a non-professional orchestra program for young people of all nationalities aged between 12 and 22. The project began the enrollment for the first course in Hanoi
The Traffic Police Department is studying changes to the current format of car registration plates, according to its deputy director Do Thanh Binh. Possible changes include new font and the addition of a QR code, the national flag and symbol of the car’s year of production, Mr. Binh said. It
Two-way trade between Vietnam and Laos hit 1.3 billion USD in 2021, a year-on-year rise of 30%, according to the 44th meeting of the Vietnam-Laos Inter-governmental Committee in Hanoi on Monday. This figure also exceeded the target set by the two countries. At the meeting co-chaired by Prime Minister Pham
14,818 new infections of COVID-19 were recorded in 62 provinces and cities in Vietnam on Monday. The country also reported 89,842 recoveries the same day, bringing the total number of patients free from coronavirus to 1,590,090. Vietnam has so far detected more than 1,914,393 COVID-19 cases including 34,531 deaths.
Khondrion completes enrolment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders NIJMEGEN, the Netherlands – 10 January 2022: Khondrion, a clinical stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial diseases, today announced that the last patient has been dosed with sonlicromanol in
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently cleared for use by US FDA to aid in distinguishing between bacterial and viral infection on the point-of-need platform MeMed Key® HAIFA, Israel; BOSTON, MA; January 10th, 2022 – MeMed, a leader in host response technologies,
Nyxoah Provides General Corporate Update Transformational 2021 positions Nyxoah for further clinical, regulatory, and commercial milestones in 2022 Mont-Saint-Guibert, Belgium – January 10, 2022, 7:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative
